BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38070651)

  • 1. Quantifying a potential protective effect of buprenorphine on fatality risk during acute fentanyl exposures.
    Dai Z; Abate MA; Winstanley E; Kraner JC; Lundstrom E; Mock AR; Smith GS
    J Subst Use Addict Treat; 2024 Mar; 158():209252. PubMed ID: 38070651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis.
    Wightman RS; Perrone J; Scagos R; Krieger M; Nelson LS; Marshall BDL
    J Med Toxicol; 2021 Jan; 17(1):10-15. PubMed ID: 32648229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Unintentional Deaths Among Buprenorphine Users.
    Dai Z; Limen GN; Abate MA; Kraner JC; Mock AR; Smith GS
    J Stud Alcohol Drugs; 2023 Jan; 84(1):171-179. PubMed ID: 36799687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
    Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
    Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History.
    Abbasi AB; Salisbury-Afshar E; Jovanov D; Berberet C; Arunkumar P; Aks SE; Layden JE; Pho MT
    J Urban Health; 2019 Feb; 96(1):38-48. PubMed ID: 30607879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW.
    Cowan E; Perrone J; Dziura J; Edelman EJ; Hawk K; Herring A; McCormack R; Murphy A; Phadke M; Fiellin DA; D'Onofrio G
    J Emerg Med; 2023 Oct; 65(4):e357-e365. PubMed ID: 37716904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and opioid analgesics: Dispensation and discontinuity among accidental overdose fatalities in the Indianapolis metropolitan area, 2016-2021.
    Victor G; Ray B; Del Pozo B; Jaffe K; King A; Huynh P
    J Subst Use Addict Treat; 2023 Jul; 150():209053. PubMed ID: 37105266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic.
    Tanz LJ; Jones CM; Davis NL; Compton WM; Baldwin GT; Han B; Volkow ND
    JAMA Netw Open; 2023 Jan; 6(1):e2251856. PubMed ID: 36662523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.
    Adams JW; Duprey M; Khan S; Cance J; Rice DP; Bobashev G
    Harm Reduct J; 2023 Oct; 20(1):150. PubMed ID: 37848945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015.
    Walley AY; Bernson D; Larochelle MR; Green TC; Young L; Land T
    Public Health Rep; 2019; 134(6):667-674. PubMed ID: 31577519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine Treatment Intake and Critical Encounters following a Nonfatal Opioid Overdose.
    Victor GA; Bailey K; Ray B
    Subst Use Misuse; 2021; 56(7):988-996. PubMed ID: 33749520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological and pharmacologic sex differences in unintentional or undetermined opioid overdose death.
    Wightman RS; Perrone J; Scagos R; Hallowell BD; Krieger M; Li Y; McGregor AJ; Nelson LS; Marshall BDL
    Drug Alcohol Depend; 2021 Oct; 227():108994. PubMed ID: 34482038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine infrequently found in fatal overdose in New York City.
    Paone D; Tuazon E; Stajic M; Sampson B; Allen B; Mantha S; Kunins H
    Drug Alcohol Depend; 2015 Oct; 155():298-301. PubMed ID: 26305073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper.
    Bozinoff N; Men S; Kurdyak P; Selby P; Gomes T
    JAMA Netw Open; 2022 Sep; 5(9):e2234168. PubMed ID: 36173629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl-associated fatalities among illicit drug users in Wayne County, Michigan (July 2005-May 2006).
    Algren DA; Monteilh CP; Punja M; Schier JG; Belson M; Hepler BR; Schmidt CJ; Miller CE; Patel M; Paulozzi LJ; Straetemans M; Rubin C
    J Med Toxicol; 2013 Mar; 9(1):106-15. PubMed ID: 23359211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FASTER-BUP Study, Extended-Release Injectable Buprenorphine for the Treatment of Opioid Use Disorder Among Individuals at High Risk of Overdose: Protocol for an Observational Prospective Study.
    Langlois J; Nolan S; Dickhout P; Cui Z; Paterson J; Fairbairn N; Socías ME
    Subst Use Addctn J; 2024 Apr; 45(2):176-180. PubMed ID: 38254287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder.
    Gryczynski J; Nichols H; Schwartz RP; Mitchell SG; Hill P; Wireman K
    Drug Alcohol Depend; 2019 Nov; 204():107515. PubMed ID: 31525569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.